Drug aimed at strengthening neurons to treat Alzheimer’s fails in trial
A dark horse effort to treat Alzheimer’s disease, already marred by a data manipulation scandal, fell short in a randomized trial reported Tuesday afternoon. Athira
A dark horse effort to treat Alzheimer’s disease, already marred by a data manipulation scandal, fell short in a randomized trial reported Tuesday afternoon. Athira
What You Should Know: – Sonio, a medical technology company focused on women’s and children’s health, announced today that it has been acquired by Samsung
Greece’s antitrust regulator is investigating allegations that, over a nine-year period, Novartis paid doctors and institutions to prescribe a pricey treatment for a serious eye
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has awarded grants for 10 projects to improve diagnostic tools for congenital
Despite what we’ve been led to believe, the timing of evening screen use, rather than the activity itself, negatively impacts youth sleep, a University of
The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource
Dive Brief: Embecta received 510(k) clearance from the Food and Drug Administration on Friday for its first insulin patch pump. The device can be used
Dive Brief: The European Court of Justice, setting aside a lower court’s judgment, ruled Tuesday that the European Commission did not have the authority to
Dive Brief: The Advanced Research Projects Agency for Health (ARPA-H) has started a program to maintain the performance of medical tools that use artificial intelligence.
Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately.